IP Library Granted Patent US 10,245,429
Granted Patent B2
US 10,245,429 · App. 15/946,919 · Granted Apr 2, 2019

Methods and apparatus for renal neuromodulation

Inventors: Mark E. Deem (Mountain View, CA); Hanson Gifford, III (Woodside, CA); Denise Zarins (Saratoga, CA); Douglas Sutton (Pacifica, CA); Erik Thai (San Jose, CA); Mark Gelfand (New York, NY); Howard R. Levin (Teaneck, NJ)
Assignee: Medtronic Ardian Luxembourg S.a.r.l.
A61N1/36007A61B8/0891A61B8/12A61B18/1206A61B18/1233A61B18/1492A61B18/18A61M5/14A61M25/0023A61N1/05A61N1/0551A61N1/18A61N1/205A61N1/327A61N1/3606A61N1/36017A61N1/36057A61N1/36103A61N1/36114A61N1/36139A61N5/00A61N7/00A61B2018/0022A61B2018/00071A61B2018/00214A61B2018/00267A61B2018/00404A61B2018/00434A61B2018/00505A61B2018/00511A61B2018/00577A61B2018/00613A61B2018/00642A61B2018/00904A61B2018/126A61B2018/1467A61N1/0412A61N1/326A61N1/36117A61N2007/003A61N2007/0021
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,245,429
App. No.
15/946,919
Granted
Apr 2, 2019
Kind
B2
Abstract

Methods and apparatus are provided for renal neuromodulation using a pulsed electric field to effectuate electroporation or electrofusion. It is expected that renal neuromodulation (e.g., denervation) may, among other things, reduce expansion of an acute myocardial infarction, reduce or prevent the onset of morphological changes that are affiliated with congestive heart failure, and/or be efficacious in the treatment of end stage renal disease. Embodiments of the present invention are configured for percutaneous intravascular delivery of pulsed electric fields to achieve such neuromodulation.

Claims (23)

1. A method for catheter-based renal denervation of a hypertensive human patient, the method comprising:

intravascularly positioning a distal region of a catheter within a renal artery associated with a kidney of the patient; and

at least partially ablating target neural tissue innervating the kidney of the patient via ultrasound energy from the catheter, wherein the ultrasound energy is delivered via an ultrasound transducer carried by a shaft of the catheter,

wherein at least partially ablating the target neural tissue results in a therapeutically beneficial reduction in blood pressure of the patient.

2. The method of claim 1 , further comprising removing the catheter from the patient after at least partially ablating the target neural tissue via the ultrasound energy to conclude the procedure.

3. The method of claim 1 wherein at least partially ablating the target neural tissue innervating the kidney further results in a therapeutically beneficial reduction in central sympathetic overactivity of the patient.

4. The method of claim 1 wherein the ultrasound energy is unfocused ultrasound energy.

5. The method of claim 1 wherein the ultrasound energy is high frequency ultrasound energy.

6. The method of claim 1 wherein intravascularly positioning a distal region of a catheter within a renal artery comprises intravascularly positioning the catheter over a guidewire.

7. The method of claim 1 , further comprising monitoring a parameter of the catheter and/or tissue within the patient before and during delivery of ultrasound energy.

8. The method of claim 7 , further comprising altering delivery of ultrasound energy in response to the monitored parameter.

9. The method of claim 1 wherein the distal region of the catheter further comprises an expandable centering element, and wherein the method further comprises transforming the centering element between a low-profile delivery configuration and an expanded configuration after intravascularly positioning the distal region of the catheter within the renal artery and before delivering the ultrasound energy via the ultrasound transducer.

10. The method of claim 9 wherein the expandable centering element comprises a balloon.

11. A method, comprising:

intravascularly advancing an energy delivery element carried by a catheter within renal vasculature of a human patient and proximate to renal nerves of the patient; and

delivering unfocused ultrasound energy via the energy delivery element, wherein the ultrasound energy inhibits neural traffic along the renal nerves to and/or from a kidney of the patient,

wherein inhibiting the neural traffic along the renal nerves results in a therapeutically beneficial reduction in blood pressure of the patient.

12. The method of claim 11 wherein inhibiting neural traffic along the renal nerves via the ultrasound energy comprises blocking afferent and/or efferent renal nerve activity.

13. The method of claim 11 wherein a distal portion of the catheter further comprises an expandable positioning element, and wherein intravascularly advancing an energy delivery element within renal vasculature of the patient comprises positioning the catheter within a renal artery of the patient via the expandable positioning element before delivering the unfocused ultrasound energy via the energy delivery element.

14. The method of claim 13 wherein the expandable positioning element comprises an inflatable balloon.

15. The method of claim 11 , further comprising intravascularly removing the catheter and energy delivery element from the patient after delivering the unfocused ultrasound energy to conclude the procedure.

16. The method of claim 11 wherein inhibiting neural traffic along the renal nerves via the ultrasound energy comprises reducing renal sympathetic nerve activity of the kidney of the patient.

17. The method of claim 11 wherein inhibiting neural traffic along the renal nerves via the ultrasound energy comprises denervating the kidney of the patient.

Assignments (3)
CHANGE OF NAME Recorded Feb 18, 2019
From: ARDIAN, INC.
To: MEDTRONIC ARDIAN LLC
Reel/Frame 049388/0176 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 18, 2019
From: DEEM, MARK; GIFFORD, HANSON, III; DEMARAIS, DENISE; SUTTON, DOUGLAS; THAI, ERIK; GELFAND, MARK; LEVIN, HOWARD R.
To: ARDIAN, INC.
Reel/Frame 048360/0066 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 18, 2019
From: MEDTRONIC ARDIAN LLC
To: MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L.
Reel/Frame 048360/0121 →
Continuity (17)
Continuation 15667781 · Aug 3, 2017
Continuation 15141764 · Apr 28, 2016
Continuation 15019793 · Feb 9, 2016
Continuation 14636317 · Mar 3, 2015
Continuation 14056888 · Oct 17, 2013
Continuation 13930863 · Jun 28, 2013
Continuation 13619851 · Sep 14, 2012
Continuation 12777892 · May 11, 2010
Continuation 11782451 · Jul 24, 2007
Division 11129765 · May 13, 2005
Continuation In Part 10408665 · Apr 8, 2003
Provisional Application 60616254 · Oct 5, 2004
Provisional Application 60624793 · Nov 2, 2004
Provisional Application 60370190 · Apr 8, 2002
Provisional Application 60415575 · Oct 3, 2002
Provisional Application 60442970 · Jan 29, 2003
Related Publication 20180229033A1 · Aug 16, 2018
Cited By (14)
US 12,274,833 US 12,336,753 US 12,349,928 US 12,419,662 US 12,440,165 US 12,496,089 US 12,527,494 US 12,575,775 US 12,594,185 US 12,594,405 US 12,636,470 US 12,653,559 US 12,661,032 US 12,685,585